Tal Zvi Zaks
CIK 1690927 · Chief Medical Officer · last filed 2026-08-10
Tal Zvi Zaks is a Chief Medical Officer who has filed 92 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider sold $593 of TEVA on Aug 10, 2026. Across all open-market trades the lifetime net is −$124.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions. 13 SEC filings were submitted jointly with TEVA PHARMACEUTICAL INDUSTRIES LTD.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MRNA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
60 JUBILEE AVE, MILTON PARK
ABINGDON, OXFORDSHIRE, X0 OX14 4RX
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEVA | Director | 73,247 | $40.39 | $2.96M | -$593 | 11 | 2026-08-10 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 3 | 2022-07-01 |
| MRNA | Chief Medical Officer | 5,000 | $207.97 | $1.04M | -$124.16M | 74 | 2021-07-02 |
| ASND | Director | — | $245.85 | — | $0 | 4 | 2019-07-03 |
Recent Filings
92 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-10 | TEVA | Sell (S) | −17 | -$593 | EDGAR |
| 2026-06-08 | TEVA | Exer (M) | +14,492 | $0 | EDGAR |
| 2026-06-01 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | TEVA | Mixed | +9,632 | $0 | EDGAR |
| 2024-06-17 | TEVA | Exer (M) | +21,108 | $0 | EDGAR |
| 2024-06-10 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2023-08-07 | TEVA | Exer (M) | +15,810 | $0 | EDGAR |
| 2023-06-20 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2022-11-07 | TEVA | Exer (M) | +12,205 | $0 | EDGAR |
| 2022-08-08 | TEVA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.